ChemoCentryx, Inc. Contracts & Agreements

Agreement and Plan of Merger, dated August 3, 2022, by and among ChemoCentryx, Inc., Amgen Inc. and Carnation Merger Sub, Inc (Filed With SEC on August 4, 2022)

Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on May 10, 2022)

Employment Agreement, effective as of October 5, 2021, by and between the Registrant and Rita Jain (Filed With SEC on March 1, 2022)

Second Amendment to Amended and Restated Loan and Security Agreement (Filed With SEC on March 1, 2022)

First Amendment to Amended and Restated Loan and Security Agreement (Filed With SEC on November 9, 2021)

Offer Letter between the Company and Rita I. Jain, dated October 5, 2021 (Filed With SEC on October 12, 2021)

Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on May 3, 2021)

Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 1, 2021)

Employment Agreement, effective as of December 28, 2020, by and between the Registrant and Tausif Butt (Filed With SEC on March 1, 2021)

Manufacturing and Supply Agreement, effective as of October 29, 2020 between the Registrant and Vifor Fresenius Medical Care Renal Pharma Ltd (Filed With SEC on March 1, 2021)

Commercial Manufacturing Agreement, dated as of August 26, 2020, by and between the Registrant and Hovione LLC (Filed With SEC on November 9, 2020)

Lease Extension Letter, dated July 1, 2020, by and between Google Inc. and the Registrant (Filed With SEC on November 9, 2020)

Master Manufacturing Services Agreement, dated as of March 18, 2020, by and between the Registrant and Patheon Pharmaceuticals Inc (Filed With SEC on August 10, 2020)

Product Agreement, dated as of May 8, 2020, by and between the Registrant and Patheon Pharmaceuticals Inc (Filed With SEC on August 10, 2020)

Underwriting Agreement, dated June 10, 2020, by and among ChemoCentryx, Inc. and SVB Leerink LLC and Piper Sandler & Co., as representatives of the several underwriters named... (Filed With SEC on June 11, 2020)

Amended and Restated Loan and Security Agreement, dated as of January 8, 2020, by and between the Registrant and Hercules Capital, Inc (Filed With SEC on May 11, 2020)

Right to Invest Agreement, dated as of January 8, 2020, by and between the Registrant and Hercules Capital, Inc (Filed With SEC on May 11, 2020)

Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on May 11, 2020)

Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 10, 2020)

Third Amendment to Lease, dated May 1, 2019, by and between Google Inc. and the Registrant (Filed With SEC on August 5, 2019)

Amendment No. 1 to Loan and Security Agreement, dated as of December 13, 2018, by and between the Registrant and Hercules Capital, Inc (Filed With SEC on March 11, 2019)

Equity Distribution Agreement, dated as of December 4, 2018, by and between ChemoCentryx, Inc. and Piper Jaffray & Co (Filed With SEC on December 4, 2018)

Letter Agreement dated as of June 6, 2018 between the Registrant and Vifor (International) Ltd. regarding Grant of Rights to CCX168 in China (Filed With SEC on August 9, 2018)

Letter Agreement dated as of June 6, 2018 between the Registrant and Vifor (International) Ltd. regarding Grant of Rights to CCX140 in China (Filed With SEC on August 9, 2018)

Amendment to Collaboration and License Agreement, effective as of June 6, 2018 between the Registrant and Vifor Fresenius Medical Care Renal Pharma Ltd (Filed With SEC on August 9, 2018)

Non-Employee Director Compensation Policy (Filed With SEC on May 9, 2018)

Employment Agreement, effective as of May 2, 2016, by and between the Registrant and Rajinder Singh (Filed With SEC on March 12, 2018)

Employment Agreement, effective as of October 11, 2016, by and between the Registrant and Jan Hillson (Filed With SEC on March 12, 2018)

Employment Agreement, dated January 3, 2018, by and between ChemoCentryx, Inc. and William Fairey (Filed With SEC on January 8, 2018)

Loan and Security Agreement, dated as of December 28, 2017, by and between the Registrant and Hercules Capital, Inc (Filed With SEC on January 4, 2018)

CERTAIN MATERIAL (INDICATED BY ASTERISKS) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTEDMATERIAL HAS BEEN FILED SEPARATELY WITH... (Filed With SEC on August 8, 2017)

SECOND AMENDMENT TO LEASE (Filed With SEC on August 8, 2017)

CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FORCONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY... (Filed With SEC on May 10, 2017)

CHEMOCENTRYX, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (As Amended and Restated Effective March 1, 2017) (Filed With SEC on May 10, 2017)

COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on March 14, 2017)

CHEMOCENTRYX, INC. 2012 EQUITY INCENTIVE AWARD PLAN RESTRICTED STOCK AWARD GRANT NOTICE AND RESTRICTED STOCK AWARD AGREEMENT (Filed With SEC on March 14, 2017)

CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY... (Filed With SEC on August 9, 2016)

CHEMOCENTRYX, INC. STOCK PURCHASE AGREEMENT (Filed With SEC on August 9, 2016)

CHEMOCENTRYX, INC. 2012 EQUITY INCENTIVE AWARD PLAN RESTRICTED STOCK UNIT AWARD GRANT NOTICE AND RESTRICTED STOCK UNIT AWARD AGREEMENT (Filed With SEC on August 8, 2014)

CHEMOCENTRYX, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (As Amended and Restated Effective February 19, 2014) (Filed With SEC on March 14, 2014)

CHEMOCENTRYX, INC. 5,000,000 Shares of Common Stock Underwriting Agreement (Filed With SEC on April 17, 2013)

First Amendment to Lease Agreement (Filed With SEC on November 13, 2012)

CHEMOCENTRYX, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on May 10, 2012)

CHEMOCENTRYX, INC. Shares of Common Stock Underwriting Agreement (Filed With SEC on January 23, 2012)

CHEMOCENTRYX, INC. AMENDED AND RESTATED 1997 STOCK OPTION/STOCKISSUANCE PLAN ARTICLE ONE GENERAL PROVISIONS (Filed With SEC on January 23, 2012)

CHEMOCENTRYX, INC. AMENDED AND RESTATED 2002 EQUITY INCENTIVE PLAN (As Amended) (Filed With SEC on January 23, 2012)

CHEMOCENTRYX, INC. 2012 EQUITY INCENTIVE AWARD PLAN ARTICLE 1. PURPOSE (Filed With SEC on January 23, 2012)

CHEMOCENTRYX, INC. 2012 EMPLOYEE STOCK PURCHASE PLAN ARTICLE 1. PURPOSE (Filed With SEC on January 23, 2012)

CHEMOCENTRYX, INC. INCENTIVE PLAN ARTICLE 1. PURPOSE (Filed With SEC on January 23, 2012)

INDEMNIFICATION AGREEMENT (Filed With SEC on January 23, 2012)

PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT BETWEEN GLAXO GROUPLIMITED and CHEMOCENTRYX, INC. TABLE OF CONTENTS (Filed With SEC on January 6, 2012)

CHEMOCENTRYX, INC. AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT SEPTEMBER 8, 2011 TABLE OF CONTENTS (Filed With SEC on October 14, 2011)

CHEMOCENTRYX, INC. WARRANT FOR THE PURCHASE OF SHARESOF COMMON STOCK (Filed With SEC on October 14, 2011)

CHEMOCENTRYX, INC. WARRANT FOR THE PURCHASE OF SHARESOF SERIES B PREFERRED STOCK (Filed With SEC on October 14, 2011)

CONVERTIBLE NOTE LOAN AGREEMENT (Filed With SEC on October 14, 2011)

CHEMOCENTRYX, INC. AMENDED AND RESTATED 1997 STOCK OPTION/STOCKISSUANCE PLAN ARTICLE ONE GENERAL PROVISIONS (Filed With SEC on October 14, 2011)

CHEMOCENTRYX, INC. AMENDED AND RESTATED 2002 EQUITY INCENTIVE PLAN (As Amended) (Filed With SEC on October 14, 2011)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on October 14, 2011)

STANDARD INDUSTRIAL/COMMERCIAL MULTI-TENANT LEASE NET AIRCOMMERCIAL REAL ESTATE ASSOCIATION (Filed With SEC on October 14, 2011)

PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT BETWEEN GLAXO GROUPLIMITED and CHEMOCENTRYX, INC. TABLE OF CONTENTS (Filed With SEC on October 14, 2011)

AMENDMENT NO. 1 to PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on October 14, 2011)

AMENDMENT NO. 2 to PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on October 14, 2011)

AMENDMENT NO. 3 to PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on October 14, 2011)

AMENDMENT NO. 4 to PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on October 14, 2011)

AMENDMENT NO. 5 to PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on October 14, 2011)

AMENDMENT TO SERIES D PREFERRED STOCK SUBSCRIPTION AGREEMENT (Filed With SEC on October 14, 2011)

SERIES E PREFERRED STOCK SUBSCRIPTION AGREEMENT (Filed With SEC on October 14, 2011)

LOAN AND SECURITY AGREEMENT (Filed With SEC on October 14, 2011)

AMENDMENT NO. 2 TO LOAN AND SECURITY AGREEMENT (Filed With SEC on October 14, 2011)

CHEMOCENTRYX, INC. 2008 EQUITY INCENTIVE AWARD PLAN (Filed With SEC on January 14, 2008)

CHEMOCENTRYX, INC. 2008 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on January 14, 2008)

INDEMNIFICATION AGREEMENT (Filed With SEC on January 14, 2008)

PRODUCT DEVELOPMENT AND COMMERCIALIZATIONAGREEMENT BETWEEN GLAXO GROUP LIMITED and (Filed With SEC on December 20, 2007)

to PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on December 20, 2007)

1 of 58 (Filed With SEC on December 20, 2007)

CHEMOCENTRYX, INC. AMENDED AND RESTATED (Filed With SEC on November 9, 2007)

CHEMOCENTRYX, INC. 1997 STOCK OPTION/STOCK ISSUANCE PLAN (Filed With SEC on November 9, 2007)

CHEMOCENTRYX, INC. AMENDED AND RESTATED 2002 EQUITY INCENTIVE PLAN (Filed With SEC on November 9, 2007)

STANDARD INDUSTRIAL/COMMERCIAL MULTI-TENANT LEASE NET AIR COMMERCIAL REAL ESTATEASSOCIATION (Filed With SEC on November 9, 2007)

AMENDMENT TO SERIES D PREFERRED STOCK SUBSCRIPTION AGREEMENT (Filed With SEC on November 9, 2007)